M. Messier

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response

A. Theamboonlers, Y. Poovorawan, V. Chongsrisawat, 2013, Human vaccines & immunotherapeutics.

Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine

P. van Damme, K. Van Herck, P. Crasta, 2012, Human vaccines & immunotherapeutics.

Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.

L. Friedland, B. Howe, W. Weston, 2011, Vaccine.

Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine

G. Icardi, S. Esposito, S. Kuriyakose, 2012, Human vaccines & immunotherapeutics.

Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.

P. van Damme, S. Kuriyakose, P. McIntyre, 2011, Vaccine.

Clarification to Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8:813-8

P. Crasta, U. Behre, M. Messier, 2012, Human vaccines & immunotherapeutics.

Antibody persistence and immune memory in adults, 15 years after a three‐dose schedule of a combined hepatitis A and B vaccine

P. van Damme, G. Leroux-Roels, K. Van Herck, 2012, Journal of medical virology.

Anti-HBs antibody persistence following primary vaccination with an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency

M. Jadoul, P. Peeters, S. Houard, 2011, Human vaccines.